Biofil Chemicals & Pharmaceuticals Board Meeting Date
Biofil Chemicals intimates that its Board will meet on 14 Nov 2026 to approve unaudited Q1/H1 FY27 results. No financial figures or other material outcomes are disclosed yet.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Biofil Chemicals intimates that its Board will meet on 14 Nov 2026 to approve unaudited Q1/H1 FY27 results. No financial figures or other material outcomes are disclosed yet.
The company submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30th September 2026, confirming compliance with depository norms.
Biofil Chemicals & Pharmaceuticals shareholders approved the continuation of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director, despite him exceeding 75 years of age.
Biofil Chemicals and Pharmaceuticals Limited held its 41st Annual General Meeting on 23rd September 2026. Members transacted routine business, including adoption of financial statements and director re-appointments.